TCL Archive DCT Board Approves Proposals For Increased Efforts With Biological Response Modifiers, Oks Contracts November 9, 1979
TCL Archive Phase III Study: Rituxan Improved PFS By 79% In Advanced Follicular Lymphoma December 31, 2010
TCL Archive Authorization Legislation Still On Congress Busy Agenda, Along With Risk Assessment, Appropriations February 3, 1984